Showing results (191-200 of 317) with videos related to
Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancerJ M Blazeby, T Conroy, A Bottomley, et al.British Journal of Cancer|March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II studyE Van Cutsem, L Dirix, J-L Van Laethem, et al.Annals of Surgery|November 23, 2000
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomyT Lerut, P Flamen, N Ectors, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximabW De Roock, H Piessevaux, J De Schutter, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Anticoagulant repertoire of the hookworm Ancylostoma caninumP Stassens, P W Bergum, Y Gansemans, et al.Nederlands Tijdschrift Voor Geneeskunde|November 16, 2012
[Lung cancer staging by endobronchial ultrasound with transbronchial needle aspiration]Niels J M Claessens, Klaartje W Maas, J A Alain Kummer, et al.British Journal of Cancer|November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumabS Siena, M Peeters, E Van Cutsem, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapyE Van Cutsem, S Siena, Y Humblet, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II studyE Van Cutsem, M Findlay, B Osterwalder, et al.ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.Pageof 32